Themis Medicare, a company in the Pharmaceuticals industry, reported revenue of ₹90 crore and net profit of ₹7.06 crore for the September 2026 quarter.
Themis Medicare (NSE: THEMISMED) closed at ₹94.87 on 20 Nov 2026, down 15.7% over the past year. Its market capitalisation is ₹874 crore.
Incorporated in 1969, Themis Medicare manufactures Formulation and API pharmaceutical products
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.